Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Medtronic and DASI Simulations Partner to Advance the Future of TAVR Through Predictive Modeling and Personalized Planning
Healthcare & PharmaceuticalPartnerships

Medtronic and DASI Simulations Partner to Advance the Future of TAVR Through Predictive Modeling and Personalized Planning

October 21, 2025 11:00 AM

Medtronic plc, a global leader in healthcare technology, and DASI Simulations, a leader in AI-driven predictive modeling and digital-twin technology, today announced a strategic partnership to enhance access to DASI technology to optimize outcomes for patients undergoing transcatheter aortic valve replacement (TAVR) in the United States. This program marks a significant step forward in both Medtronic's and DASI's mission to deliver innovative,...

Read more
Debuting the
Healthcare & PharmaceuticalCompany Update

Debuting the "The Power of a Smile" Scholarship

October 21, 2025 11:00 AM

Sunshine State Dentistry wants to make it easier for incoming and current college students to overcome the financial burdens standing between them and their long-term goals. Beginning this year, students can apply for the team's "The Power of a Smile" Scholarship, which promises its winning student $2,500 in financial support. Applicants are invited to submit a two- to three-minute video reflecting on the connection between oral health and...

Read more
Pete Sessa to Present
Healthcare & PharmaceuticalAdvertorial

Pete Sessa to Present "Unlocking Radical Human Connection for Societal Change" at Cannadelic Global

October 21, 2025 10:00 AM

The Cannadelic Global Summit, the nation's premier event at the intersection of psychedelics, cannabis, and wellness innovation, proudly announces that Pete Sessa, co-founder of Cannadelic, will headline the 2025 speaking lineup with his TED-style talk titled: "Unlocking Radical Human Connection for Societal Change" Taking place Saturday, November 9, 2025, at 2201 1st Ave S, St. Petersburg, FL, Sessa's presentation will explore how restoring...

Read more
Heather Riley Heimstra Returns to Cannadelic Global Summit with Groundbreaking Workshop on
Healthcare & PharmaceuticalConferences

Heather Riley Heimstra Returns to Cannadelic Global Summit with Groundbreaking Workshop on "Sexual Healing and the Endocannabinoid System"

October 21, 2025 10:00 AM

The Cannadelic Global Summit is proud to welcome back Heather Riley Heimstra, co-founder of Rockstar Blends, for an encore presentation of her electrifying and deeply transformative workshop, "Sexual Healing and the Endocannabinoid System." The session is scheduled to take place on November 9, 2025, at 2201 1st Ave S, St. Petersburg, FL - and it's already generating buzz among attendees, educators, and wellness advocates. Last year's session was...

Read more
Study Shows CLn BodyWash Helps People With Hidradenitis Suppurativa (HS) Improve Comfort and Confidence
Healthcare & PharmaceuticalProduct Announcements

Study Shows CLn BodyWash Helps People With Hidradenitis Suppurativa (HS) Improve Comfort and Confidence

October 21, 2025 9:00 AM

CLn Skin Care, a dermatologist-recommended therapeutic skincare leader, announced results from a recent study evaluating the use of CLn BodyWash in people living with Hidradenitis Suppurativa (HS). This chronic inflammatory skin condition impacts daily comfort, confidence, and quality of life. The study was organized and conducted by HS Connect, an HS patient advocacy group. Click here to view the full study. The study followed 145 participants...

Read more
Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System
Healthcare & PharmaceuticalProduct Announcements

Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System

October 21, 2025 8:30 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SImmetry+ SI Joint Fusion System. The SImmetry+ System is indicated for sacroiliac (SI) joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis, providing...

Read more
VSee Health (Nasdaq:VSEE) Secures Game-Changing 10M+ Teleradiology Contract, Igniting Explosive Growth in Booming Telehealth Sector
Healthcare & PharmaceuticalPartnerships

VSee Health (Nasdaq:VSEE) Secures Game-Changing 10M+ Teleradiology Contract, Igniting Explosive Growth in Booming Telehealth Sector

October 21, 2025 8:09 AM

VSee Health, Inc. (Nasdaq:VSEE), a trailblazing leader in telehealth innovation, is thrilled to announce a monumental multi-year teleradiology contract that catapults the Company into a new era of unprecedented growth and shareholder value creation. Executed on May 7, 2025, with service delivery underway since June 15, 2025, this landmark deal with a premier Level 1 hospital system is set to double VSee's annual recurring revenue and unlock a...

Read more
Dr. Angela Fisher's Invitation to Reimagine Love at Cannadelic Global
Healthcare & PharmaceuticalAdvertorial

Dr. Angela Fisher's Invitation to Reimagine Love at Cannadelic Global

October 21, 2025 8:00 AM

Ahead of her headline keynote at the Cannadelic Global Summit, Dr. Angela Fisher is calling on seekers, clinicians, couples, and skeptics alike to explore one question: What if love is not a feeling, but a frequency we can return to - on purpose? Her talk, "From Blushing to Bonding," will guide the audience through the erotic neurobiology of connection - a live demonstration of how safety, tension, and intimacy actually work inside the body....

Read more
Investors at a Crossroads: Remote Monitoring, Wellness Apps, and Oversold Health IT Categories Face a 2025 Funding Recession as ROI Fatigue Sets In
Healthcare & PharmaceuticalConferences

Investors at a Crossroads: Remote Monitoring, Wellness Apps, and Oversold Health IT Categories Face a 2025 Funding Recession as ROI Fatigue Sets In

October 21, 2025 8:00 AM

According to a new Black Book Research pre-HLTH25 survey of 77 institutional and strategic investors controlling $22 billion in deployable capital, the digital health market is entering a correction phase as capital shifts from consumer-facing apps and devices to AI-driven operational platforms with measurable ROI. Capital Rotation Accelerates The survey reveals an unmistakable rotation: 69% of investors are reducing or exiting...

Read more
CellRight Technologies, LLC Announces Update and Senior Leadership Changes
Healthcare & PharmaceuticalRegulatory

CellRight Technologies, LLC Announces Update and Senior Leadership Changes

October 21, 2025 7:50 AM

CellRight Technologies, LLC, a specialist in regenerative osteoinductive bone scaffolds for patient implants, announces the following organisational changes, whilst remaining focussed on restoring Group revenue growth and profitability, and driving sustainable, long-term growth. Jay LeCoque, newly appointed Executive Chairman of Tissue Regenix, has been appointed acting CEO and Executive Chairman, replacing Daniel Lee as Chief Executive Officer,...

Read more
Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth
Healthcare & PharmaceuticalMergers and Acquisitions

Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth

October 21, 2025 7:30 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing therapies that target epigenetic drivers of cancer, aging, and age-related disease, today announced that it has executed a binding Letter of Intent (the "LOI") to acquire TELI Pharmaceuticals, Inc., securing worldwide rights to its lead investigational therapy, Telomir-1. The transaction aligns Telomir's U.S. rights with...

Read more
CBD Life Sciences Inc. (CBDL) Launches First-of-Its-Kind Mushroom-Infused
Healthcare & PharmaceuticalCompany Update

CBD Life Sciences Inc. (CBDL) Launches First-of-Its-Kind Mushroom-Infused "Dubai Chocolate Bar"

October 21, 2025 7:00 AM

CBD Life Sciences Inc. (OTC PINK:CBDL), through its wholly owned subsidiary CBD Vault, is proud to announce the official launch of its Mushroom-Infused Dubai Chocolate Bar, a premium fusion of functional wellness and luxury indulgence. Inspired by the decadent chocolate culture of Dubai, each bar combines pistachio-filled layers with rich, velvety chocolate and is infused with Cordyceps and Reishi mushroom extracts, two of the most powerful...

Read more
Neutec Group Guides Buyers From Product Discovery to Product Validation With Bioz Badges
Healthcare & PharmaceuticalPartnerships

Neutec Group Guides Buyers From Product Discovery to Product Validation With Bioz Badges

October 21, 2025 4:00 AM

Bioz, Inc., a pioneering AI platform changing the way companies present research-backed product evidence, is proud to announce a new partnership with Neutec Group. With the addition of Bioz Badges on their product webpages, and an innovative placement of Bioz Micro Badges within the website's navigation menu, Neutec is setting a new standard in delivering instant scientific proof to their customers. At the heart of this integration is Neutec's...

Read more
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
Healthcare & PharmaceuticalCompany Update

BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study

October 21, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies, is pleased to announce the launch of an important large-mass animal bioequivalence study for its lead product, BNT23001, a proprietary sublingual Cladribine formulation for the treatment of multiple sclerosis ("MS"). This is the final animal study to generate dosing parameters for...

Read more
Only 27% of European Hospitals Achieve Full Patient Data Exchange Across Borders Despite EU Interoperability Mandates
Healthcare & PharmaceuticalRegulatory

Only 27% of European Hospitals Achieve Full Patient Data Exchange Across Borders Despite EU Interoperability Mandates

October 21, 2025 3:00 AM

As Europe advances toward the European Health Data Space (EHDS), a new Black Book Research regional pulse survey exposes persistent interoperability barriers stalling seamless cross-border data exchange. While interoperability readiness has improved by nine percentage points since 2023, a fraction of European hospitals report achieving full cross-border data liquidity , meaning structured, standards-based patient information can flow freely...

Read more
The Piazza Center in Austin Offers New AlloClae Treatment
Healthcare & PharmaceuticalProduct Announcements

The Piazza Center in Austin Offers New AlloClae Treatment

October 20, 2025 2:00 PM

The Piazza Center for Plastic Surgery & Advanced Skin Care is among the first in the Austin area to offer AlloClae, an innovative, FDA-compliant injectable fat filler revolutionizing non-surgical enhancements for hips, breasts, and buttocks. This cutting-edge treatment provides a minimally invasive solution for patients seeking natural-looking volume restoration without the complexities of traditional surgery. AlloClae, is an innovative...

Read more
U.S. Olympic Athlete Ashley Hoffman Becomes Sam Brand Ambassador for Active Living With Knee Osteoarthritis
Healthcare & PharmaceuticalCompany Update

U.S. Olympic Athlete Ashley Hoffman Becomes Sam Brand Ambassador for Active Living With Knee Osteoarthritis

October 20, 2025 9:00 AM

Olympic athletes need the most advanced methods to perform at the highest level of sport and to recover from workouts and injuries. After competing in field hockey at the 2024 Paris Olympic Games, Ashley Hoffman turned to the sam® wearable ultrasound unit from ZetrOZ Systems to manage her knee osteoarthritis. As the latest sam® brand ambassador, Hoffman is sharing how the wearable ultrasound device helps with her knee problems. "I really like to...

Read more
NEW SURVEY: Four in Five Americans Support Reforms to the Patent System to Lower Drug Prices
Healthcare & PharmaceuticalEnvironmental, Social and Governance

NEW SURVEY: Four in Five Americans Support Reforms to the Patent System to Lower Drug Prices

October 20, 2025 9:00 AM

The Initiative for Medicines, Access and Knowledge (I-MAK) released findings from a comprehensive survey of 726 American adults examining public attitudes toward prescription drug pricing and potential reforms. Conducted by Franklin & Marshall College's Center for Opinion Research in June 2025, the survey reveals unprecedented bipartisan consensus on the urgent need for prescription drug reform, with patent reform emerging as the most...

Read more
A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus
Healthcare & PharmaceuticalCompany Update

A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus

October 20, 2025 8:45 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in a humanized animal model. The Company announces that NV-387 can now be made available for emergency use application in Measles patients to respond to the spreading Measles outbreaks. Having a drug to treat patients has become of paramount importance, in view of...

Read more
Med-X to Exhibit its Nature-Cide Division at the PestWorld Conference in Orlando from October 21-24, 2025
Healthcare & PharmaceuticalConferences

Med-X to Exhibit its Nature-Cide Division at the PestWorld Conference in Orlando from October 21-24, 2025

October 20, 2025 8:31 AM

Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced its participation at PestWorld 2025, scheduled October 21-24 at the Marriott Orlando World Center in Orlando, Florida. Med-X's leadership team will present the full Nature-Cide product portfolio to pest management professionals, distributors, and industry leaders and stakeholders. Each year, the...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
A blue background with the word access on it
By Jennifer Hammers • June 14, 2026
Compare ACCESS Newswire vs Cision PR Newswire on pricing, features, reach, and reviews — and why companies are making the switch..
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?